SCHEMBL5450835

SCHEMBL5450835

CCOC(=O)C1CCc2c(sc(NC(=O)C3CC3)c2C(N)=O)C1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.62
FLT3 P36888 2/20 0.59
REV1 Q9UBZ9 2/20 0.56
MAPT P10636 4/20 0.52
DUSP3 P51452 1/20 0.52
PTPN5 P54829 1/20 0.52
PTPN11 Q06124 1/20 0.52
AIP O00170 1/20 0.51
SGTA O43765 1/20 0.51
TOMM70 O94826 1/20 0.51
STIP1 P31948 1/20 0.51
PPP5C P53041 1/20 0.51
DNAJC7 Q99615 1/20 0.51
STUB1 Q9UNE7 1/20 0.51
KDM4E B2RXH2 4/20 0.49
ALDH1A1 P00352 3/20 0.49
HPGD P15428 2/20 0.49
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
LIMK1 P53667 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21597418 0.83 MAPT (0.49) POLBFLT3MAPTKDM4EALDH1A1
SCHEMBL5451971 0.83 FLT3 (0.68) POLBFLT3REV1MAPTDUSP3
SCHEMBL5448468 0.83 FLT3 (0.68) POLBFLT3REV1MAPTDUSP3
SCHEMBL5755697 0.83 FLT3 (0.68) POLBFLT3REV1MAPTDUSP3
SCHEMBL5451294 0.82 ALDH1A1 (0.60) POLBMAPTKDM4EALDH1A1HPGD
SCHEMBL5451299 0.82 ALDH1A1 (0.60) POLBMAPTKDM4EALDH1A1HPGD
SCHEMBL8291584 0.81 REV1 (0.61) POLBFLT3REV1MAPTDUSP3
SCHEMBL5447659 0.81 TNIK (0.58) POLBFLT3MAPTDUSP3PTPN5
SCHEMBL3916303 0.80 REV1 (0.79) POLBFLT3REV1MAPTDUSP3
SCHEMBL5467337 0.80 TNIK (0.57) POLBMAPTDUSP3PTPN5PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents GPC BIOTECH AG (DE) 2007-11-29 US claimed
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents GPC BIOTECH AG (DE) 2007-11-29 US disclosed
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents GPC BIOTECH AG (DE) 2007-11-29 US disclosed
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents GPC BIOTECH AG (DE) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275962-A1 Heterobicyclic Compounds as Pharmaceutically Active Agents TBCA, PARK7, NFATC1 POLB 404/4885FLT3 3509/4885REV1 1861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.